-
公开(公告)号:US20190239515A1
公开(公告)日:2019-08-08
申请号:US16389147
申请日:2019-04-19
Applicant: Academia Sinica
Inventor: Yet-Ran Chen , Ying-Lan Chen , Mei-Chun Tseng
IPC: A01N65/38 , C12N15/82 , C07K14/415
CPC classification number: A01N65/38 , A61K38/00 , C07K14/415 , C12N15/8271 , C12N15/8279
Abstract: The present invention related to a novel plant defense signaling peptide and applications thereof.
-
公开(公告)号:US10342818B2
公开(公告)日:2019-07-09
申请号:US14849782
申请日:2015-09-10
Applicant: Academia Sinica
Inventor: Yun-Lian Lin , Yijuang Chern , Jim-Min Fang , Jung-Hsing Lin , Nai-Kuei Huang
IPC: A01N43/04 , A61K31/70 , A61K31/7076 , C07H19/167 , A61K31/706 , A61K31/7064
Abstract: The present invention provides therapeutic agents for preventing and treating neurodegenerative diseases. These agents synergistically target both the adenosine A2A receptor (A2AR) and the equilibrative nucleoside transporter 1 (ENT1).
-
公开(公告)号:US20190192487A1
公开(公告)日:2019-06-27
申请号:US16233280
申请日:2018-12-27
Applicant: Academia Sinica
Inventor: Chinpan CHEN , Tien-Sheng TSENG , Keng-Chang TSAI
IPC: A61K31/422 , A61K45/06 , A61K31/385
CPC classification number: A61K31/422 , A61K31/385 , A61K45/06
Abstract: Disclosed herein are novel uses of a compound of formula (I) as an inhibitor of bacterial two component signal transduction system (TCS), A-L-B-L-A (I) wherein, A is a moiety having a negative charge; L is —(C2H5—O)n—CH2— or a moiety consists of a carbocyclyl and a heterocyclyl respectively having 5 to 10 ring atoms and coupling together, in which n is 0 or 1; and B is a 5 to 10-membered carbocyclyl or heterocyclyl. The compound of formula (I) may suppress or inhibit the growth of bacteria, including the notorious multi-drug resistant bacteria.
-
公开(公告)号:US10329570B2
公开(公告)日:2019-06-25
申请号:US15500354
申请日:2015-07-31
Applicant: Academia Sinica , National Taiwan University
Inventor: Pan-Chyr Yang , Yi-Chung Chang , Wei-Yun Lai
IPC: C12N15/11 , C12N15/115 , A61K31/7088 , C12N15/113 , A61K31/713 , C12N15/117 , A61K47/60
Abstract: Aptamers that bind to and antagonize programmed cell death protein 1 (PD-1). Also provided herein are pharmaceutical compositions comprising such anti-PD-1 aptamers and methods for using the same for promoting T cell proliferation, treating cancer or infectious diseases, such as human immunodeficiency virus (HIV) infection.
-
公开(公告)号:US10317393B2
公开(公告)日:2019-06-11
申请号:US15729317
申请日:2017-10-10
Applicant: Academia Sinica
Inventor: Chi-Huey Wong , Tsui-Ling Hsu , Sarah R. Hanson , Masaaki Sawa
IPC: G01N33/50 , G01N33/533
Abstract: Methods for metabolic oligosaccharide engineering that incorporates derivatized alkyne-bearing sugar analogs as “tags” into cellular glycoconjugates are disclosed. Alkynyl derivatized Fuc and alkynyl derivatized ManNAc sugars are incorporated into cellular glycoconjugates. Chemical probes comprising an azide group and a visual or fluorogenic probe and used to label alkyne-derivatized sugar-tagged glycoconjugates are disclosed. Chemical probes bind covalently to the alkynyl group by Cu(I)-catalyzed [3+2] azide-alkyne cycloaddition and are visualized at the cell surface, intracellularly, or in a cellular extract. The labeled glycoconjugate is capable of detection by flow cytometry, SDS-PAGE, Western blot, ELISA, confocal microscopy, and mass spectrometry.
-
公开(公告)号:US10283714B2
公开(公告)日:2019-05-07
申请号:US15421221
申请日:2017-01-31
Applicant: ACADEMIA SINICA , National Taiwan University
Inventor: Kuang-Lieh Lu , Muhammad Usman , Yang-Fang Chen , Golam Haider , Shruti Mendiratta , Tzuoo-Tsair Luo
Abstract: An organic electroluminescent material is shown in the following general formula (1), {[M(L)(H2O)x].(H2O)y}n General Formula (1) wherein x is between 1 and 4, y is between 1 and 8, and n is a positive integer. M is any one selected from the group consisting of beryllium (Be), strontium (Sr), and radium (Ra). L is an organic ligand containing a naphthalene group and an anhydride group. M and L form metal-organic frameworks. An organic electroluminescent device containing the organic electroluminescent material is also disclosed.
-
公开(公告)号:US10238631B2
公开(公告)日:2019-03-26
申请号:US15316700
申请日:2015-06-05
Applicant: Academia Sinica
Inventor: Lie-Fen Shyur , Kuo-Hsiung Lee , Kyoko Nakagawa-Goto , Jia-Hua Feng , Jo-Yu Chen , Wai-Leng Lee , Yu-Ting Cheng , Jing-Ying Huang
IPC: A61K31/365 , A61K45/06 , A61K31/337 , A61K31/437 , C07D493/18 , A61K31/198 , A61K31/655
Abstract: A new class of sesquiterpene derivative useful for treating cancerous and inflammatory diseases are disclosed. These deoxyelephantopin derivatives are effective in suppressing proliferation, migration, mobility, invasion, growth, and/or metastasis of cancer cells in a patient, or useful for enhancing an anti-proliferative effect of another anti-cancer drug on cancer cells when treating a patient, or for sensitizing and/or enhancing an anti-cancer effect of a gluthathione synthesis blocker on inhibition of triple negative breast cancer cell activity, or for treatment and/or prophylaxis of lipopolysaccharide-stimulated inflammatory response in a patient, or for all of the above. Also disclosed are methods of preparing the deoxyelephantopin derivatives.
-
公开(公告)号:US10214765B2
公开(公告)日:2019-02-26
申请号:US15881581
申请日:2018-01-26
Applicant: Academina Sinica
Inventor: Chi-Huey Wong , Jim-Min Fang , Yih-Shyun E. Cheng , Chamg-Sheng Tsai
Abstract: Provided herein are compounds for use as sialidase inhibitors, including alkynyl-3-fluorosialyl fluoride. The compounds, which include the compound DFSA, function by trapping a 3-fluorosialylenzyme intermediate (reporter-inhibitor-enzyme conjugate). These compounds can be conjugated with a detectable tagging moiety for isolation and identification of sialidases.
-
公开(公告)号:US10213967B2
公开(公告)日:2019-02-26
申请号:US14302243
申请日:2014-06-11
Applicant: ACADEMIA SINICA
Inventor: Keng-Hui Lin , Yi-Hsuan Lee
IPC: B29C67/20 , B29K77/00 , B29K105/00 , B29K105/04 , B29K105/24
Abstract: A fabricating device of a three-dimensional (3-D) scaffold comprises a bubble generator, a bubble mixing channel, a coagulating solution channel and a bubble collector. The bubble generator includes a gas channel and a gel solution channel crossing the gas channel. The bubble mixing channel is connected with a first outlet of the bubble generator. The coagulating solution channel is connected with the bubble mixing channel. The bubble collector is connected with a second outlet of the bubble mixing channel.
-
公开(公告)号:US10117890B2
公开(公告)日:2018-11-06
申请号:US15376281
申请日:2016-12-12
Applicant: Academia Sinica
Inventor: Chih-Cheng Chen , Yun-Lian Lin , Jim-Min Fang , Yijuang Chern , Chia-Ching John Lin , Wei-Nan Chen , Chun-Jung Lin
IPC: A01N43/04 , A61K31/70 , A61K31/7076 , A61K36/8988 , A61K45/06
Abstract: Methods for treating pain such as fibromyalgia, comprising administering to a subject in need thereof an effective amount of an adenosine analog, wherein the adenosine analog may be a compound of Formula (I): (I), or a pharmaceutically acceptable salt thereof. Pharmaceutical compositions comprising the adenosine analog for use in treating pain (e.g., fibromyalgia), optionally further comprising Substance P (SP), are also provided.
-
-
-
-
-
-
-
-
-